| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.079 | 0.06 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |